Hepatitis C News and Research

Latest Hepatitis C News and Research

Trump pledges to end HIV transmission by 2030. Doable, but daunting.

Noting that science has "brought a once-distant dream within reach," President Donald Trump on Tuesday night pledged to eliminate HIV transmission within 10 years.

6 Feb 2019

Trump highlights health agenda with vow to lower ‘unfair’ drug prices

It was not the centerpiece, but health was a persistent theme in President Donald Trump's State of the Union address at the Capitol on Tuesday night.

6 Feb 2019

American Gastroenterological Association announces 2019 recipients of annual recognition awards

The American Gastroenterological Association (AGA) has announced the 2019 recipients of the annual recognition awards, given in honor of outstanding contributions and achievements in gastroenterology.

4 Feb 2019

Researchers use integrated data analysis to classify liver cancer

Liver cancer remains a major problem in healthcare globally, being the second most common cause of cancer-related death globally.

3 Feb 2019

New drug for sleeping sickness approved in the Democratic Republic of Congo

Marketing authorization of fexinidazole for the treatment of Trypanosoma brucei gambiense human African trypanosomiasis (HAT), more commonly known as sleeping sickness, has been granted in the Democratic Republic of Congo (DRC).

31 Jan 2019

New research collaboration between EU and Russia focuses on infectious diseases

A new EU project on the theme of HIV, hepatitis C and tuberculosis is a door opener for collaboration between researchers from EU countries and Russia.

28 Jan 2019

Standard method for ranking liver transplant waitlists may not prioritize the sickest candidates

A new study has uncovered that the standard method for ranking patients on the waitlist for lifesaving liver transplantation may not prioritize some of the sickest candidates for the top of the list.

25 Jan 2019

Study reveals cost-effectiveness of needle and syringe programs in preventing HCV transmission

Providing clean injecting equipment through needle and syringe programmes is a highly cost-effective way of preventing hepatitis C transmission among people who inject drugs and could save millions of pounds in infection treatment costs in the UK, according to research led by the University of Bristol and London School of Hygiene & Tropical Medicine.

24 Jan 2019

Trump zeroes in on surprise medical bills in White House chat with patients, experts

President Donald Trump on Wednesday instructed administration officials to investigate how to prevent surprise medical bills, broadening his focus on drug prices to include other issues of price transparency in health care.

23 Jan 2019

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).

23 Jan 2019

Alcohol-linked disease overtakes hep C as top reason for liver transplant

An estimated 17,000 Americans are on the waiting list for a liver transplant, and there's a strong chance that many of them have alcohol-associated liver disease. ALD now edges out hepatitis C as the No. 1 reason for liver transplants in the United States, according to research published Tuesday in JAMA Internal Medicine.

23 Jan 2019

Hepatitis C-infected patients with a history of liver cancer can be treated with antivirals

A large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer.

18 Jan 2019

Combination therapy shows high efficacy in treating people with leishmaniasis and HIV

The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative, in partnership with Médecins Sans Frontières, the University of Gondar, and Addis Ababa University, open the way for more effective and safer treatments for people with both HIV and visceral leishmaniasis, a group of patients who have historically suffered from poor treatment options.

18 Jan 2019

Many cancer patients have undiagnosed hepatitis

A new report has described an alarmingly high rate of undiagnosed acute and chronic hepatitis B and hepatitis C in patients with cancer.

17 Jan 2019

Research suggests possible way to improve survival in African-Americans undergoing liver transplant

Among African-American adults undergoing liver transplant to treat liver cancer, patients whose organ donor was also African-American lived significantly longer than those with a racially unmatched donor, report authors of a new study using national data.

10 Jan 2019

NYSCF announce partnership with Ngene to develop new disease treatments

The New York Stem Cell Foundation Research Institute today announced a partnership with Ngene Therapeutics Inc. to develop new disease treatments that leverage human stem cell research and novel gene editing techniques.

10 Jan 2019

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Drugs that can cure hepatitis C revolutionized care for millions of Americans living with the deadly liver infection. The drugs came with a steep price tag — one that prompted state Medicaid programs to initially limit access to the medications to only the sickest patients.

4 Jan 2019

Court decision to stop further cuts in 340B reimbursements protects patient care

The Dec. 27 federal court injunction stopping further cuts in 340B reimbursements for Medicare Part B drugs to some participating hospitals is a critical step in preserving the role that academic health centers play in providing HIV, viral hepatitis, and other infectious disease treatment and prevention services to patients who otherwise lack care options.

2 Jan 2019

Himalayan marmot genome offers clues to high-altitude adaptation

Himalayan marmots can survive at altitudes up to 5,000 meters in the Himalayan regions of India, Nepal, and Pakistan and on the Qinghai-Tibetan Plateau of China, where many of them face extreme cold, little oxygen, and few other resources.

27 Dec 2018

Study reveals how Hepatitis C infection varies by state and region

Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.

24 Dec 2018

Hepatitis C News and Research

Latest Hepatitis C News and Research

Trump pledges to end HIV transmission by 2030. Doable, but daunting.

Trump highlights health agenda with vow to lower ‘unfair’ drug prices

American Gastroenterological Association announces 2019 recipients of annual recognition awards

Researchers use integrated data analysis to classify liver cancer

New drug for sleeping sickness approved in the Democratic Republic of Congo

New research collaboration between EU and Russia focuses on infectious diseases

Standard method for ranking liver transplant waitlists may not prioritize the sickest candidates

Study reveals cost-effectiveness of needle and syringe programs in preventing HCV transmission

Trump zeroes in on surprise medical bills in White House chat with patients, experts

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Alcohol-linked disease overtakes hep C as top reason for liver transplant

Hepatitis C-infected patients with a history of liver cancer can be treated with antivirals

Combination therapy shows high efficacy in treating people with leishmaniasis and HIV

Many cancer patients have undiagnosed hepatitis

Research suggests possible way to improve survival in African-Americans undergoing liver transplant

NYSCF announce partnership with Ngene to develop new disease treatments

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Court decision to stop further cuts in 340B reimbursements protects patient care

Himalayan marmot genome offers clues to high-altitude adaptation

Study reveals how Hepatitis C infection varies by state and region

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in